Rajeswara Rao Arasada
Accomplished Scientist and Oncology Medical Affairs Professional
- Role
- Field Medical Director at Pfizer
- Location
- Columbus, OH, US
- LinkedIn followers
- 500 followers
About Rajeswara Rao Arasada
Medical affairs professional with 22 years of oncology experience including target identification, translational research, biomarker development, clinical trials, medical and regulatory affairs and strategic leadership in academia and the pharmaceutical industry. • Three drug launch experience in oncology space and 8 years of managerial experience that includes eight direct reports, recruiting around fifteen faculty members and oncology fellows, annual review, managing budgets. Demonstrated experience working with cross-functional groups to meet project milestones and timelines at industry and academic setting.• Extensive knowledge in oncology therapeutics involving various therapeutic modalities with 12 years of hands-on experience in understanding and developing novel therapeutics to address unmet medical needs including two early phase trials and clinical biomarker development.• Demonstrated ability to develop projects, build collaborative relationships at intercontinental level with renowned leaders in oncology, and pharmaceutical industry to achieve clinical research and medical affair goals. • Articulate communicator with solid track record of publications and presentations on oncology at national and international conferences and meetings.
Experience
Field Medical Director
May 2022 — Present
Field Medical Director supporting prostate, bladder and renal cell carcinoma (Genito Urinary Cancers) in Ohio, Michigan and Western Pennsylvania. Relugolix co-lead and contributed to medical affairs strategy, reviewed medical information and publications. Co-lead nationwide health care professional (HCP) advisory board at headquarters. Supported two drug launches and established trusting relationships with HCPs in various clinical settings. Provided actionable insights on approved products, Enzalutamide, Talazoparib, Relugolix, Avelumab and Axitinib. Led major alliance meeting bringing cross-functional teams from Pfizer and alliance partners to major cancer center and established collaborations.Pipeline presentations at various health care organizations and supported Investigator Initiated Studies (IIS) Conducted extensive outreach on homologous recombination repair (HRR) genes-based biomarker in prostate cancer management. Therapeutic knowledge on GU cancers management and comprehensive understanding of various therapeutic modalities that will help change the way we treat cancers.McKinsey \"Management Accelerator Program\" completed (4 month long leadership program sponsored by Pfizer).
Education
University of Hyderabad
Master of Science (M.Sc.), Plant Sciences and Environmental Sciences
1994 — 1996
The Ohio State University
Master of Science - MS, Master of Applied Clinical and Preclinical Research (MACPR)
2019 — 2020
Indian Institute of Science (IISc)
Doctor of Philosophy (PhD), Microbiology and Cell Biology
1996 — 2002
Skills
- Drug Testing
- Microbiology
- Cell Biology
- Cell
- Protein Purification
- Molecular Biology
- Flow Cytometry
- Facs Analysis
- High-Throughput Screening of Sirnas
- Drug Screening
- Molecular Cloning
- Tissue Culture
- Molecular Imaging
- Transfection
- In Vivo
- Cancer Research
- Cancer Stem Cells
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.